Retracted: Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV‐1‐infected T lymphocytes in vitro
暂无分享,去创建一个
[1] M. Furihata,et al. Analysis of Aurora B kinase in non-Hodgkin lymphoma , 2009, Laboratory Investigation.
[2] P. Opolon,et al. The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe , 2009, Cell cycle.
[3] M. Toyota,et al. Retracted: Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV‐1‐infected T cells through enhanced NF‐κB activity , 2009, International journal of cancer.
[4] J. Fitzgibbon,et al. AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo. , 2009, Cancer research.
[5] J. Pollard,et al. Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.
[6] Oliver Gautschi,et al. Aurora Kinases as Anticancer Drug Targets , 2008, Clinical Cancer Research.
[7] Tony Reiman,et al. The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma , 2008, British journal of haematology.
[8] L. Galluzzi,et al. Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway , 2007, PloS one.
[9] J. Bourhis,et al. Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152 , 2007, Oncogene.
[10] Rajesh Odedra,et al. AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis , 2007, Clinical Cancer Research.
[11] Kuan-Teh Jeang,et al. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.
[12] N. Keen,et al. Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase. , 2007, Journal of medicinal chemistry.
[13] G. Schwartz,et al. Aurora Kinases: New Targets for Cancer Therapy , 2006, Clinical Cancer Research.
[14] B. Sullivan,et al. Regulation of mitotic chromosome cohesion by Haspin and Aurora B. , 2006, Developmental cell.
[15] M. Loda,et al. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.
[16] D. Ballinari,et al. PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity , 2006, Clinical Cancer Research.
[17] J. Schellens,et al. Phase I and pharmacological study of the novel aurora kinase inhibitor AZD1152. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] T. Tang,et al. Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis. , 2006, Developmental biology.
[19] Stephen S. Taylor,et al. Aurora-kinase inhibitors as anticancer agents , 2004, Nature Reviews Cancer.
[20] J. Choe,et al. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein , 2004, Oncogene.
[21] J. Brady,et al. Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1 , 2004, Oncogene.
[22] David Bebbington,et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.
[23] Erich A Nigg,et al. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. , 2004, Current opinion in genetics & development.
[24] W. Earnshaw,et al. The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.
[25] Meeting abstracts , 2003 .
[26] Stephen S. Taylor,et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.
[27] J. Peters,et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint , 2003, The Journal of cell biology.
[28] R. Margolis,et al. G1 tetraploidy checkpoint and the suppression of tumorigenesis , 2003, Journal of cellular biochemistry.
[29] M. Tomonaga,et al. Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells , 1999 .
[30] M. Tomonaga,et al. Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells , 1999 .
[31] Brian Schryver,et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.
[32] M. Ishiyama,et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. , 1996, Biological & pharmaceutical bulletin.
[33] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[34] C Haanen,et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.
[35] Yuetsu Tanaka,et al. Heterogeneity of Antigen Molecules Recognized by Anti‐tax1 Monoclonal Antibody Lt‐4 in Cell Lines Bearing Human T Cell Leukemia Virus Type I and Related Retroviruses , 1990, Japanese journal of cancer research : Gann.
[36] H. Saya,et al. Aurora-A — A guardian of poles , 2005, Nature Reviews Cancer.